Pharmaceutical - Quintiles, Research

Filter

Current filters:

QuintilesResearch

Popular Filters

Therapeutic effects of Eisai's lenvatinib in melanoma confirmed

12-06-2013

Japanese drug major Eisai (TYO: 4523) says that the therapeutic effects of lenvatinib, a VEGF receptor…

EisailenvatinibOncologyPharmaceuticalQuintilesResearch

Merck Serono and Quintiles enter novel clinical development partnership

16-05-2013

Merck Serono, the biotech division of Germany's Merck KGaA (MRK: DE) and Quintiles (NYSE: Q) have announced…

BiotechnologyMerck KGaAMerck SeronoPharmaceuticalQuintilesResearch

Quintiles expands operations in China

18-06-2012

US-headquartered biopharma services provider Quintiles yesterday announced agreements to establish a…

Asia-PacificBiotechnologyFinancialPharmaceuticalQuintilesResearch

Quintiles to expand clinical development capabilities in Russia

26-02-2012

Biopharmaceutical services company Quintiles is moving further into emerging markets, last week signing…

EuropePharmaceuticalQuintilesRegulationResearchRVC Biofund

Back to top